Dr Brett Jared Goodwin, MD | |
600 Dr Michael Debakey Dr, Lake Charles, LA 70601-5727 | |
(337) 436-3813 | |
(337) 439-0214 |
Full Name | Dr Brett Jared Goodwin |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 14 Years |
Location | 600 Dr Michael Debakey Dr, Lake Charles, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235457870 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0011X | Internal Medicine - Interventional Cardiology | 304880 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Christus Ochsner St Patrick Hospital | Lake charles, LA | Hospital |
Beauregard Memorial Hospital | Deridder, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Physical Therapy Services Of West Louisiana Inc | 0446388763 | 69 |
Christus Health Southwestern Louisiana | 5799695839 | 6 |
Imperial Health Llp | 7719886779 | 76 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Entity Name | Imperial Health Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053352401 PECOS PAC ID: 7719886779 Enrollment ID: O20040108000257 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Entity Name | Christus Health Southwestern Louisiana |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629076468 PECOS PAC ID: 5799695839 Enrollment ID: O20040511000095 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Entity Name | West Louisiana Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164985495 PECOS PAC ID: 5799680245 Enrollment ID: O20110216000789 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Entity Name | Cardiac Cath Lab Of Lake Charles Lp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033565320 PECOS PAC ID: 0244523868 Enrollment ID: O20160720000391 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brett Jared Goodwin, MD 600 Dr Michael Debakey Dr, Lake Charles, LA 70601-5727 Ph: (337) 436-3813 | Dr Brett Jared Goodwin, MD 600 Dr Michael Debakey Dr, Lake Charles, LA 70601-5727 Ph: (337) 436-3813 |
News Archive
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs).
Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
A new study published on the medRxiv* preprint server presents a standardized survey instrument for evaluating risk factors associated with bidirectional zoonotic transmission of SARS-CoV-2 and pathogens. The instrument is particularly focused on settings where humans and animals share close contact.
› Verified 9 days ago
Robin Ann Rougeau, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 South Ryan St, #101, Lake Charles, LA 70601 Phone: 337-439-0762 Fax: 337-436-8862 | |
Dr. Jean King White, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. William R Condos Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1717 Oak Park Blvd, Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Leroy E Fredericks, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 210, Lake Charles, LA 70601 Phone: 337-494-6768 Fax: 337-494-6792 | |
Gerald W Byrd, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 Dr Michael Debakey Dr, Lake Charles, LA 70601 Phone: 337-433-8400 Fax: 337-433-7350 | |
Hari Bogabathina, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 Oak Park Blvd Fl 2, Lake Charles, LA 70601 Phone: 337-494-3278 Fax: 337-494-3240 | |
Dr. Eric Charles Fontenot, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2770 3rd Ave Ste 345, Lake Charles, LA 70601 Phone: 337-494-4785 Fax: 337-494-4786 |